CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease

International Journal of Cancer

Volumn 133, Issue 6, 2013, Pages 1293-1299

  Bierkens, Mariska ^a   Hesselink, Albertus T ^a   Meijer, Chris J L M ^a   Heideman, Daniëlle A M ^a   Wisman, G Bea A ^b   Van Der Zee, Ate G J ^b   Snijders, Peter J F ^a   Steenbergen, Renske D M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

cervical scrapes; DNA methylation; high grade cervical intraepithelial neoplasia; Human papillomavirus; tumour suppressor genes

Indexed keywords

CELL ADHESION MOLECULE; CELL ADHESION MOLECULE 1; MYELIN AND LYMPHOCYTE PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CADM1 GENE; CANCER GRADING; CANCER GROWTH; CONTROLLED STUDY; CYTOLOGY; DISEASE DURATION; DISEASE SEVERITY; DNA METHYLATION; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAL GENE; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DISEASE;

CERVICAL SCRAPES, HUMAN PAPILLOMAVIRUS; DNA METHYLATION; HIGH-GRADE CERVICAL INTRAEPITHELIAL NEOPLASIA; TUMOUR SUPPRESSOR GENES;

ADULT; CELL ADHESION MOLECULES; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; DNA METHYLATION; FEMALE; HUMANS; IMMUNOGLOBULINS; MIDDLE AGED; MYELIN AND LYMPHOCYTE-ASSOCIATED PROTEOLIPID PROTEINS; PAPILLOMAVIRIDAE; PROMOTER REGIONS, GENETIC; UTERINE CERVICAL NEOPLASMS;

EID: 84879918997     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28138     Document Type: Article

References (36)

1. zur Hausen H,. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000; 92: 690-8.
2. Baseman JG, Koutsky LA,. The epidemiology of human papillomavirus infections. J Clin Virol 2005; 32 (Suppl 1): S16-S24.
3. Snijders PJ, Steenbergen RD, Heideman DA, et al. HPV-mediated cervical carcinogenesis: concepts and clinical implications. J Pathol 2006; 208: 152-64.
4. Winer RL, Kiviat NB, Hughes JP, et al. Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis 2005; 191: 731-8.
5. McCredie MR, Sharples KJ, Paul C, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 2008; 9: 425-34.
6. Wilting SM, Steenbergen RD, Tijssen M, et al. Chromosomal signatures of a subset of high-grade premalignant cervical lesions closely resemble invasive carcinomas. Cancer Res 2009; 69: 647-55.
7. Bierkens M, Wilting SM, Van Wieringen WN, et al. Chromosomal profiles of high-grade cervical intraepithelial neoplasia relate to duration of preceding high-risk human papillomavirus infection. Int J Cancer 2012; 131: E579-85.
8. Wentzensen N, Sherman ME, Schiffman M, et al. Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science. Gynecol Oncol 2009; 112: 293-9.
9. Steenbergen RD, Kramer D, Braakhuis BJ, et al. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia. J Natl Cancer Inst 2004; 96: 294-305.
10. Overmeer RM, Henken FE, Snijders PJ, et al. Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC. J Pathol 2008; 215: 388-97.
11. Overmeer RM, Henken FE, Bierkens M, et al. Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis. J Pathol 2009; 219: 327-36.
12. Overmeer RM, Louwers JA, Meijer CJ, et al. Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women. Int J Cancer 2011; 129: 2218-25.
13. Hesselink AT, Heideman DA, Steenbergen RD, et al. Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women. Clin Cancer Res 2011; 17: 2459-65.
14. Wentzensen N, Schiffman M, Dunn ST, et al. Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma. Int J Cancer 2009; 124: 964-9.
15. Bulkmans NW, Rozendaal L, Snijders PJ, et al. POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women. Int J Cancer 2004; 110: 94-101.
16. Rijkaart DC, Berkhof J, Rozendaal L, et al. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial. Lancet Oncol 2012; 13: 78-88.
17. Eijsink JJ, Lendvai A, Deregowski V, et al. A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients. Int J Cancer 2012; 130: 1861-9.
18. Hanselaar AGJM,. Criteria for organized cervical screening programs-special emphasis on the Netherlands program. Acta Cytologica 2002; 46: 619-29.
19. Bulk S, van Kemenade FJ, Rozendaal L, et al. The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996. J Clin Pathol 2004; 57: 388-93.
20. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002; 287: 2114-9.
21. van den Brule AJ, Pol R, Fransen-Daalmeijer N, et al. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 2002; 40: 779-87.
22. Baay MF, Quint WG, Koudstaal J, et al. Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol 1996; 34: 745-7.
23. Claas EC, Melchers WJ, van der Linden HC, et al. Human papillomavirus detection in paraffin-embedded cervical carcinomas and metastases of the carcinomas by the polymerase chain reaction. Am J Pathol 1989; 135: 703-9.
24. Krul EJ, van de Vijver MH, Schuuring E, et al. Human papillomavirus in malignant cervical lesions in Surinam, a high-risk country, compared to the Netherlands, a low-risk country. Int J Gynecol Cancer 1999; 9: 206-11.
25. Harden SV, Guo Z, Epstein JI, et al. Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma. J Urol 2003; 169: 1138-42.
26. Wentzensen N, Walker J, Schiffman M, et al. Heterogeneity of high-grade cervical intraepithelial neoplasia related to HPV16: implications for natural history and management. Int J Cancer 2013; 132: 148-54.
27. Yang HP, Zuna RE, Schiffman M, et al. Clinical and pathological heterogeneity of cervical intraepithelial neoplasia grade 3. PLoS One 2012; 7: e29051.
28. Rijkaart DC, Berkhof J, van Kemenade FJ, et al. Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening. Int J Cancer 2012; 130: 602-10.
29. Yang N, Eijsink JJ, Lendvai A, et al. Methylation markers for CCNA1 and C13ORF18 are strongly associated with high-grade cervical intraepithelial neoplasia and cervical cancer in cervical scrapings. Cancer Epidemiol Biomarkers Prev 2009; 18: 3000-7.
30. Apostolidou S, Hadwin R, Burnell M, et al. DNA methylation analysis in liquid-based cytology for cervical cancer screening. Int J Cancer 2009; 125: 2995-3002.
31. Lim EH, Ng SL, Li JL, et al. Cervical dysplasia: assessing methylation status (Methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracy. Gynecol Oncol 2010; 119: 225-31.
32. Kim JH, Choi YD, Lee JS, et al. Quantitative assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens. Virchows Arch 2010; 457: 35-42.
33. Yang N, Nijhuis ER, Volders HH, et al. Gene promoter methylation patterns throughout the process of cervical carcinogenesis. Cell Oncol 2010; 32: 131-43.
34. Lin CJ, Lai HC, Wang KH, et al. Testing for methylated PCDH10 or WT1 is superior to the HPV test in detecting severe neoplasms (CIN3 or greater) in the triage of ASC-US smear results. Am J Obstet Gynecol 2011; 204: 21-27.
35. Missaoui N, Hmissa S, Trabelsi A, et al. Promoter hypermethylation of CDH13, DAPK1 and TWIST1 genes in precancerous and cancerous lesions of the uterine cervix. Pathol Res Pract 2011; 207: 37-42.
36. Sun LL, Cao DY, Yang JX, et al. Population-based case-control study on DAPK1, RAR-beta2 and MGMT methylation in liquid-based cytology. Arch Gynecol Obstet 2012; 285: 1433-9.